Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Ross

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Issues in Mental Health Nursing|June 1, 1980
The impact of group and individual therapy on socialization of residents in an institutional settingD M Ross, S L Uecker, S R Powell, et al.
Blood Cancer Journal|August 20, 2016
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia veraI S Tiong, D A Casolari, T Nguyen, et al.
Internal Medicine Journal|December 10, 2015
Practical management of myelofibrosis with ruxolitinibP J Ho, P Marlton, C Tam, et al.
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Leukemia|October 28, 2015
Delayed diagnosis leading to accelerated-phase chronic eosinophilic leukemia due to a cytogenetically cryptic, imatinib-responsive TNIP1-PDFGRB fusion geneD M Ross, H K Altamura, C N Hahn, et al.
Leukemia|April 17, 2013
Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patientsD M Ross, M O'Hely, P A Bartley, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Leukemia|February 21, 2017
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom studyA Hochhaus, T Masszi, F J Giles, et al.
Scientific Reports|May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasmD A Casolari, T Nguyen, C M Butcher, et al.
Leukemia|March 10, 2015
A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant cloneC N Hahn, D M Ross, J Feng, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Issues in Mental Health Nursing|June 1, 1980
The impact of group and individual therapy on socialization of residents in an institutional settingD M Ross, S L Uecker, S R Powell, et al.
Blood Cancer Journal|August 20, 2016
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia veraI S Tiong, D A Casolari, T Nguyen, et al.
Internal Medicine Journal|December 10, 2015
Practical management of myelofibrosis with ruxolitinibP J Ho, P Marlton, C Tam, et al.
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Leukemia|October 28, 2015
Delayed diagnosis leading to accelerated-phase chronic eosinophilic leukemia due to a cytogenetically cryptic, imatinib-responsive TNIP1-PDFGRB fusion geneD M Ross, H K Altamura, C N Hahn, et al.
Leukemia|April 17, 2013
Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patientsD M Ross, M O'Hely, P A Bartley, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Leukemia|February 21, 2017
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom studyA Hochhaus, T Masszi, F J Giles, et al.
Scientific Reports|May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasmD A Casolari, T Nguyen, C M Butcher, et al.
Leukemia|March 10, 2015
A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant cloneC N Hahn, D M Ross, J Feng, et al.
Pageof 6